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Abstract
Objectives
To evaluate the presence of viruses and bacteria in middle ear and adenoids of patients with
and without otitis media with effusion (OME).
Methods
Adenoid samples and middle ear washes (MEW) were obtained from children with OME
associated with adenoid hypertrophy undergoing adenoidectomy and tympanostomy, and
compared to those obtained from patients undergoing cochlear implant surgery, as a control
group. Specific DNA or RNA of 9 respiratory viruses (rhinovirus, influenza virus, picornavi-
rus, syncytial respiratory virus, metapneumovirus, coronavirus, enterovirus, adenovirus and
bocavirus) and 5 bacteria (S. pneumoniae, H. influenzae, M. catarrhalis, P. aeruginosa and
S. aureus) were extracted and quantified by real-time PCR.
Results
37 OME and 14 cochlear implant children were included in the study. At the adenoid, virus
and bacteria were similarly detected in both OME and control patients. At the middle ear
washes, however, a higher prevalence of bacteria was observed in patients with OME (p =
0.01). S. pneumoniae (p = 0.01) and M. catarrhalis (p = 0.022) were the bacteria responsible
for this difference. Although total virus detection was not statistically different from controls
at the middle ear washes (p = 0.065), adenovirus was detected in higher proportions in ade-
noid samples of OME patients than controls (p = 0.019).
Conclusions
Despite both OME and control patients presented similar rates of viruses and bacteria at the
adenoid, children with OME presented higher prevalence of S. pneumonia, M. catarrhalis in
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middle ear and adenovirus in adenoids when compared to controls. These findings could
suggest that these pathogens could contribute to the fluid persistence in the middle ear.
Introduction
Otitis media with effusion (OME) is a common childhood disease characterized by the pres-
ence of fluid in the middle ear, with no symptoms and/or signs of acute inflammation [1, 2]. In
the United States, approximately 90% of all children develop an episode of OME before they
reach school age, mainly between the ages of 4 months and 6 years [2]. The presence of OME
is associated with severe negative impact on child development, including hearing loss with
long-term consequences for speech and language acquisition, poor school performance, and
imbalance issues [1–3]. Moreover, children with OME are five times more susceptible to
develop acute otitis media than controls [4, 5].
The pathogenesis of OME is still not fully understood. Epidemiological data suggest that
the pathogenesis of OME is multifactorial, involving anatomical, immunological, genetic,
microbial, and environmental factors [6–9]. However, it is widely accepted that the dysfunc-
tion of the Eustachian tube play a key role in the development of OME in all ages.
Mechanical obstruction of the Eustachian tube is one of the main identifiable causes of
Eustachian tube dysfunction, especially due to adenoid hypertrophy (AH) in the pediatric age.
The presence of AH can obstruct the nasopharyngeal ostium of the Eustachian tube, leading to
negative pressure in the middle ear cavity, and eventually mucosal transudation [10]. Indeed,
AH is a frequent condition observed in patients with OME [7–9, 11]. In children with AH and
OME, the surgical removal of the adenoid (associated with ventilation tube insertion) acceler-
ates the recovery of the middle ear mucosa, decrease the risk of recurrence and need of repeti-
tive surgical procedures, and reduce treatment failure rate. However, new evidence point out
that the benefits of adenoidectomy in children with OME older than 4 years-old is indepen-
dently of the adenoid size [12], suggesting that the removal of a local reservoir of pathogenic
microbiota (viruses, planktonic bacteria, and biofilms) is the key for such benefits [13–15].
Despite some studies have evaluated the microbial colonization of adenoid and middle ear, no
studies have thoroughly studied the association of respiratory pathogenic microbiota between
these two niches. Therefore, the present study was carried out to compare the detection of
common respiratory viruses and bacteria in adenoids and middle ear fluid in children with
OME and in controls.
Moreover, adenoid can be reservoirs of pathogens that may reach the middle ear [13]. Ade-
noid samples obtained from patients with chronic adenoiditis are highly colonized by multiple
species of viruses and bacteria. The rate of detection in hypertrophic adenoids is higher than
85% for viruses [14] and almost 100% for bacteria [15].
Bacteria and viruses have been detected in the middle ear fluid (MEF) from children with
OME. Using an RT-PCR-based assay only for three respiratory viruses (rhinovirus, respiratory
syncytial virus and human coronavirus), positivity was detected in 30% of MEF from children
with OME in Finland [16]. In a study conducted in Pittsburgh, 75 of 97 (77.3%) samples of
MEF from children with OME were positive by PCR for one or more of three bacteria (M cat-
arrhalis, H influenza and S pneumoniae) [17].
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Methods
Ethics statement
The study was conducted following the principles expressed in the Declaration of Helsinki,
after approval by the Ethics Review Committee of the Clinical Hospital of the University of
Sao Paulo School of Medicine in Ribeirão Preto, Brazil (#10466/2008). Written informed con-
sent was obtained from all parents/guardians.
Patients
The study enrolled patients seen at the Division of Otorhinolaryngology from May 2010 to
August 2012. Two groups of patients were studied: a) children with OME and adenoid hyper-
trophy (AH) who underwent adenoidectomy and tympanostomy with ventilation tube inser-
tion, and b) children with no middle ear disease, who underwent cochlear implantation due to
severe hearing loss. All patients were evaluated by otoscopy, audiometry, tympanometry, and
nasal endoscopy. OME was diagnosed by medical history suggesting persistence of middle ear
fluid for more than 3 months without acute signs of inflammation, confirmed by the presence
of tympanic membrane opacity, retraction, or air-liquid interface, and by a type B tympano-
gram and/or conductive hearing loss. AH was defined at nasal endoscopy by the presence of
adenoid in contact with the torus tubaris (grade 3) and/or vomer (grade 4) [18, 19]. Exclusion
criteria were: prior surgical procedures in the upper airways, including tympanostomy for
tube placement; use of antibiotics or symptoms of respiratory infection within the last month;
history of recurrent acute otitis media or recurrent upper airways infection; tympanic mem-
brane perforation, or the presence of genetic syndromes, such as Down syndrome. All patients
with OME and AH were under treatment with nasal corticosteroids for at least one month
during the preoperative period.
The control group consisted of children undergoing cochlear implant due to severe hearing
loss with no medical history of otitis media, no respiratory infection within the last month,
absence of tympanometric alterations, nor adenotonsillar hypertrophy.
All patients followed the vaccination protocols of the Brazilian ministry of health [20],
which includes some pathogens targeted in the present study, such as pneumococcal conju-
gated. Additionally, patients in the control group were immunized with pneumococcus
23-valent vaccine and meningococcus C, according to the cochlear implant surgery protocol.
Specimen collection
Fragments of adenoid (surface and stroma) and middle ear washes (MEW) were obtained
from all patients under general anesthesia. Briefly, adenoids fragments were collected using
Beckmann adenoid curette (from OME-AH patients) or punch biopsy forceps, under direct
visualization after soft palate retraction, in order to avoid contamination (controls). Adenoids
samples were placed in Eagle’s minimal essential medium (MEM) with 15% of a solution con-
taining 20,000 U/mL of penicillin-streptomycin and 200 μg/mL of amphotericin B, 10% of
fetal bovine serum (Gibco1, Life Technologies, Carlsbad, CA, USA), and kept on ice until fur-
ther processing. Adenoids were washed twice in MEM to remove blood and tissue debris and
the fragment was macerated in Trizol1 (Invitrogen, Life Technologies, Carlsbad, CA, USA)
for later nucleic acid extraction.
In children with OME, MEW was performed with 0.5 mL of sterile saline through a small
tympanostomy using a sterile needle coupled to a 5 mL syringe, after mechanical cleaning of
the external ear canal. After that, the MEW was conditioned into a polypropylene microtube
and treated with antimycotic and antibiotic solution (Gibco1, Grand Island, NY, USA) for
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one hour at 4˚C. Aliquots were made in thrice the volume of Trizol, and frozen at −80˚C until
further processing. From each patient, samples were collected from only one side, which was
randomly chosen when bilateral disease was present.
In control patients, MEW was obtained after partial mastoidectomy was performed, when
direct access to the middle ear was possible through the attic, with the same sterile technique
utilized to collect samples in OME patients.
Nucleic acid extraction and pathogen detection
RNA was extracted from 250 μL of MEW or from approximately 30 mg of adenoid tissue
using 750 μL of Trizol1 [21], according to the manufacturer’s protocol. DNA was further
extracted using DNA purification kit (Promega1, Fitchburg, WI, USA) starting with the
DNA-enriched fraction obtained with Trizol1. Samples were tested by real-time PCR for rhi-
novirus (HRV), influenza virus (FLU), parainfluenza virus (HPIV), syncytial respiratory virus
(HRSV), metapneumovirus (HMPV), coronavirus (HCoV), enterovirus (HEV), adenovirus
(HAdV) and human bocavirus (HBoV) following an in house real-time PCR protocol, based
on primers listed on S1 Table and TaqMan probes, with the same procedures published else-
where (14]. Real-time PCR was also used to detect the presence of S. pneumoniae, H. influen-
zae, M. catarrhalis, P. aeruginosa, and S. aureus, using the primers listed on S2 Table.
Statistical analysis
The Fisher’s exact test was used to compare rates of virus and bacteria detection in both groups
of patients. Wilcoxon test was done to assess correlation between bacteria and virus detected
in each patient. The analysis was performed using GraphPad Prism 5 (La Jolla, CA, USA).
Results
Clinical data
14 control patients (2–12 years-old; mean 4 years 6 months; SD 2.64; 9 male / 5 female) and 37
children with OME and AH (2–12 years-old; mean 6 years 1 month; SD 1,97; 19 male / 18
female) were included in this study.
No severe complications related to the sampling procedure, such as nasal or oral bleeding,
dysphagia and otorrhea, were observed in the control group as well as in the OME-AH group
within the first 48 hours after surgery or after 3 weeks postoperative reassessment.
Detection of viruses
At least one virus species was detected, considering adenoid samples, in 32 of 37 (86.5%)
patients with OME-AH and in 11 of 14 (78.6%) control patients. Differently, at least one virus
was detected in MEWs from 19 of 37 (51.3%) patients with OME, and in 3 of 14 (21.4%) con-
trol patients.
The overall rates of virus detection were significantly higher in adenoids as compared to
MEW in both groups (p = 0.002 for the OME group and p = 0.007 for the control group), but
the virus detection rates in MEW and adenoids were not significantly different between
patients with OME and control children (respectively p = 0.06 and p = 0.66). Despite this
fact, HAdV was more often found in adenoids of OME-AH group as compared to controls
(p = 0.01) (Table 1).
The rates of virus co-detection in positive samples were 59.3% (19/32) in adenoids and 21%
(4/19) in MEWs. Two or 3 viruses were simultaneously detected in adenoid tissues from 15
(40.5%) and 4 (10.8%) patients with OME. In contrast, only 3 (8.1%) control patients had 2
Otitis media with effusion and adenoid hypertrophy: Pathogens profile
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viruses and only 1 (2.7%) had 3 different viruses detected in MEWs (Fig 1). There was no sig-
nificant concordance between detection of viruses in adenoid and the middle ear (p = 0.65).
Only 6 (16.2%) patients with OME (5 HEV and 1 HBoV) and 1 control patient (HEV) had the
same virus detected in MEWs and adenoid tissue, suggesting that the viral colonization of the
middle ear is independent from viral infection of adenoids.
Table 1. Viral detection in adenoid and middle ear samples from OME and control patients.
OME Patients Control Patients p-value
Virus Adenoid Middle ear Adenoid Middle ear Adenoid Middle Ear
N (%) N (%) N (%) N (%)
HEV 17 (45.9) 13 (35.1) 7 (50.0) 2 (14.2) P = 1.00 P = 0.18
HRV 5 (13.5) 2 (5.4) 2 (14.2) 1 (7.1) P = 1.00 P = 1.00
HRSV 3 (8.1) 0 (0) 4 (28.5) 0 (0) P = 0.07 P = 1.00
HMPV 3 (8.1) 5 (13.5) 2 (14.2) 0 (0) P = 0.60 P = 0.30
HPIV 0 (0) 0 (0) 2 (14.2) 0 (0) P = 0.07 P = 1.00
FLU 0 (0) 0 (0) 0 (0.0) 0 (0) P = 1.00 P = 1.00
HCoV 4 (10.8) 0 (0) 0 (0.0) 0 (0) P = 0.56 P = 1.00
HBoV 6 (16.2) 1 (2.7) 1 (7.1) 0 (0) P = 0.65 P = 1.00
HAdV 16 (43.2) 0 (0) 1 (7.1) 0 (0) P = 0.01* P = 1.00
Total 32 (86.5) 19 (51.3) 11 (78.6) 3 (21.4) P = 0.66 P = 0.06
*Valid statistical significance
doi:10.1371/journal.pone.0171049.t001
Fig 1. Percentages of single infections and co-infections by respiratory viruses in adenoids and middle ear
samples from OME and control patients.
doi:10.1371/journal.pone.0171049.g001
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Detection of bacteria
Notably, the rates of bacteria detection in MEWs was significantly higher in patients with
OME than in control patients (p = 0.01), especially due to S. pneumococcus and M. catarrhalis.
Overall bacterial detection rates in adenoids were similar between OME and control patients
(p = 0.29). Twelve of 14 control patients (85.7%) had at least one species of respiratory patho-
genic bacteria detected in adenoid tissues, reinforcing previous data that indicate that poten-
tially pathogenic bacteria colonize adenoids of healthy children [22, 23] (Table 2).
With regard to bacteria co-detection in adenoids and MEWs from OME patients, 18
patients (48.6%) with OME had more than one bacterium detected in adenoid, and two, three,
or four bacteria were simultaneously detected respectively in 16.2%, 18.9%, and 13.5% of
patients. Six patients had 2 (16.2%), four had 3 (10.8%) and two patients had 4 bacteria (5.4%)
simultaneously detected in MEWs for an overall frequency co-detection of bacteria in MEWs
of 32.4% (12 of 37 patients). Bacteria co-detection was also frequent in the control group, in
which five patients had 2, three patients had 3 and one patient had 4 different bacteria simulta-
neously detected in adenoid tissues. Bacteria co-detection was not observed in MEWs from
control patients (Fig 2).
Similar to the findings regarding viruses, there was no concordance between bacteria
detected in adenoids and MEWs, both in controls and OME patients (p = 0.18). The same bac-
teria were detected in the MEWs and adenoids was observed in 13 (35.1%) patients with OME,
and in 2 (14.2%) controls (Fig 2).
Association between virus and bacteria detection
Multiple associations between viruses and bacteria in the adenoid and middle ear were investi-
gated. The only microbes that presented positive association was S. pneumoniae and HAdV in
hypertrophic adenoids of patients with OME (p = 0.02) (Tables 3 and 4). We did not find any
significant association between virus and bacteria in the adenoid or middle ear in patients of
the control group.
Discussion
Although the pathogenesis of OME is not fully understood, there is evidence that adenoid may
play an important role in this disease, either by mechanically impairing the Eustachian tube
function, or by acting as a microbial reservoir for ascending infection to the middle ear [13, 14,
24]. Children are often exposed to pathogens that may chronically persist in tissues in the
upper airways, especially in the adenoid and tonsils [13, 14, 25, 26]. Thus, as the adenoid has
Table 2. Bacterial detection in adenoid and middle ear samples from OME and control patients.
Bacteria OME Patients Control Patients Significance
Adenoid Middle ear Adenoid Middle ear AD ME
N (%) N (%) N (%) N (%) P value P value
S. pneumoniae 21 (56.7) 13 (35.1) 9 (64.2) 0 (0) 0.75 0.01*
H. influenzae 16 (43.2) 7 (18.9) 9 (64.2) 2 (14.2) 0.22 1.00
M. catarrhalis 15 (40.5) 12 (32.4) 4 (28.5) 0 (0) 0.52 0.02*
P. aeruginosa 8 (21.6) 11 (29.7) 2 (14.2) 1 (7.1) 0.7 0.14
S. aureus 1 (2.7) 1 (2.7) 2 (14.2) 0 (0) 0.17 1.00
TOTAL 25 (67.5) 24 (64.8) 12 (85.7) 3 (21.4) 0.29 0.001*
*Valid statistical significance
doi:10.1371/journal.pone.0171049.t002
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an intimate anatomical relation with the Eustachian tube and ultimately to the middle ear, it is
important to understand how the presence of microbes in the adenoid could lead to the devel-
opment or persistence of OME in children.
To the best of our knowledge, this is the first case-control study that compared adenoid and
middle ear microbiota of OME patients with healthy children. In our study, we used a sensitive
method to detect nucleic acid of a comprehensive panel of respiratory viruses and bacteria to
compare the microbial colonization of adenoid and its correspondence in the middle ear in
both OME children and controls.
Fig 2. Percentages of single infections and co-infections by potentially pathogenic bacteria in adenoids and
middle ear samples from OME and control patients.
doi:10.1371/journal.pone.0171049.g002
Table 3. Detection of respiratory viruses and bacteria in adenoid samples in patients with OME.
Adenoid—OME S. Pneumoniae H. influenzae M. catarrhalis P. aeruginosa S. aureus Total
N (%) N (%) N (%) N (%) N (%) N (%)
HAdV 11 (29.7)* 7 (18.9) 7 (18.9) 4 (10.8) 0 (0) 13 (35.1)
HBoV 3 (8.1) 4 (10.8) 3 (8.1) 4 (10.8) 0 (0) 6 (16.2)
HRV 4 (10.8) 3 (8.1) 3 (8.1) 1 (2.7) 0 (0) 4 (10.8)
HEV 10 (27.0) 6 (16.2) 5 (13.5) 2 (5.4) 1 (2.7) 11 (29.7)
HRSV 2 (5.4) 2 (5.4) 2 (5.4) 0 (0) 0 (0) 2 (5.4)
HMPV 2 (5.4) 2 (5.4) 1 (2.7) 0 (0) 0 (0) 2 (5.4)
FLU 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
HPIV 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
HCoV 2 (5.4) 2 (5.4) 1 (2.7) 0 (0) 0 (0) 2 (5.4)
Total 20 (54.0) 15 (40.5) 14 (37.8) 8 (21.6) 1 (2.7) 24 (64.8)
*Valid statistical significance
doi:10.1371/journal.pone.0171049.t003
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The overall detection rate of bacteria in the middle ear was significantly higher in patients
with OME than in controls, but was similar for viruses. The higher overall frequency of bacte-
ria detection in MEWs from OME patients was expected, since the accumulation of middle ear
effusion favors growing of bacterial elements that may have been suctioned through the tube
from the nasopharyngeal microbiota. Moreover, these bacteria may play roles as chronic
inflammatory stimuli to the mucosa of the middle ear and contribute to the dysfunction of
Eustachian tube. There was little or no concordance of the microbe detected in the adenoid
and the middle ear, both in patients with OME as well as in controls. This finding is in agree-
ment with a previous report that performed 16S rDNA pyrosequencing of both niches, show-
ing that the adenoid microbiota was more diverse and complex than of the middle ear in a
child with OME [27]. As the adenoid is exposed to the nasal and oral microbial contents, dif-
ferently from the enclosed cavity of the middle ear, this makes the adenoid more susceptible to
be colonized by a higher load and more variety of microorganisms. It is generally accepted that
the development of negative pressure within the middle ear cavity suctions microbial compo-
nents of the nasopharyngeal microbiota but, at present, there is no enough data to rule out the
establishment of a selected microbiome especial to the middle ear cavity.
Interestingly, adenovirus detection was more frequent in hypertrophic adenoid tissues
from patients with OME than in normal adenoids from healthy controls. This is in agreement
with a paper previously published by our group reporting high rates of adenovirus detection
by PCR in hypertrophic adenoids [14]. It has not been clear whether adenovirus has any role
in pathogenesis of adenoid hypertrophy, especially because this virus is also frequent in naso-
pharyngeal secretions from healthy individuals [28]. Since some HAdV species are more
prone than others to have more prolonged shedding [29], prospective longitudinal studies of
viruses in patients with hypertrophic tonsils should include determination of adenovirus spe-
cies to evaluate whether they are associated with chronic tonsillar hypertrophy.
The observed association of HAdV with S. pneumoniae in adenoids could lead to speculate
that the epithelial damage induced by HAdV could somehow favor the secondary local prolif-
eration of S. pneumoniae [30]. Some viruses, for instance influenza, are known to favor pneu-
mococcal colonization of the upper airways by multiple mechanisms, including exposure of
receptors for pneumococcal adherence and by providing nutrients sources for bacterial growth
[31]. However, the simultaneous presence of HAdV and S. pneumoniae in adenoid tissue
Table 4. Detection of respiratory viruses and bacteria in adenoid samples from control patients undergoing cochlear implantation.
Adenoid—Control S. Pneumoniae H. influenzae M. catarrhalis P. aeruginosa S. aureus Total
N (%) N (%) N (%) N (%) N (%) N (%)
HAdV 0 (0)* 1 (7.1) 1 (7.1) 0 (0) 0 (0) 1 (7.1)
HBoV 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
HRV 1 (7.1) 2 (14.2) 2 (14.2) 0 (0) 0 (0) 2 (14.2)
HEV 5 (35.7) 4 (28.5) 2 (14.2) 1 (7.1) 0 6 (42.8)
HRSV 2 (14.2) 2 (14.2) 1 (7.1) 1 (7.1) 0 3 (21.4)
HMPV 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
FLU 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
HPIV 2 (14.2) 1 (7.1) 1 (7.1) 2 (14.2) 0 (0) 2 (14.2)
HCoV 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total 7 (50.0) 6 (42.8) 3 (21.4) 2 (14.2) 0 (0) 9 (64.2)
*Valid statistical significance
doi:10.1371/journal.pone.0171049.t004
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could be independent observations, due to the high frequencies of both microorganisms in the
adenoid.
S. pneumoniae and M. catarrhalis were detected more often in middle ear washes from
OME patients than controls. Considering that S. pneumoniae and M. catarrhalis are the most
frequent pathogens detected in acute otitis media [6], and are able to ascend through the
Eustachian tube [32], causing ciliary damage to the airway epithelium and disrupting muco-
ciliary flow, this may result in conditions for persistence in the middle ear compartment [33–
36]. In some cases, especially when OME is not clearly related to a mechanical obstruction of
the Eustachian tube, the Toynbee effect of negative pressure within the middle ear may help
ascendance of microbes through the tube, leading to colonization of the middle ear, which
may be pivotal in OME pathogenesis.
M. catarrhalis has been widely studied because of its importance in middle ear diseases, and
this interest has even led to vaccines for M. catarrhalis being proposed [37]. It’s mechanisms of
adherence and triggering of the immune response have been well studied and even when not
related to clinically relevant infection processes, appears with a high level of colonization dur-
ing childhood [38]. Once regarded as nonpathogenic, M. catarrhalis could be related to several
chronic affections of the upper airways [39].
Microorganisms in sessile biofilms are frequently resistant to the innate and adaptive
immune responses and to antimicrobial agents. In OME, there has been evidence that the pres-
ence of middle ear fluid is associated to formation of biofilm in the middle ear, and that these
biofilms are related to the local inflammation [9, 24]. In conventional, culture-based microbi-
ology, detection of these microorganisms is not always possible, and the use of sensitive molec-
ular methods, such as real-time PCR, enables detection of multiple microbes in complex
niches like the middle ear. Although PCR cannot distinguish viable from dead microbes, the
specificity of the primers coupled with careful sampling technique in order to minimize cross-
contamination between sampling sites, ensure that the microorganisms were indeed present in
the middle ear.
Viruses and bacteria interact in many different ways on different mucosal surfaces [40],
including the upper respiratory tract mucosa and tonsils [41]. Persistence of viral infections
includes a complete reprogramming of the local immune response, attenuation of production
of type 1 interferon, and local alteration of the CD4+/CD8+ T cell balance [41, 42]. The airway
mucosa affected by viral infection becomes more susceptible to bacterial adherence and muco-
sal inflammation [30, 43, 44]. Therefore, associations of viruses and bacteria could be acting in
concert to modify the course of the OME. In the present study, there was an association of
detection of HAdV and S. pneumoniae in adenoid tissues from patients with OME, suggesting
that microbial correlations already described in acute middle ear disease [16, 45] could play a
role in such chronic processes.
Clinical studies based on microbial detection in patients with adenoid hypertrophy and
OME have rarely included a healthy control group. A notable example was a study of biofilms
in middle ear samples, including adults and children [25]. Importantly, biofilms were not
observed in OME patients, but not in control specimens of middle ear mucosa obtained from
patients undergoing cochlear implantation, strongly suggesting that biofilm production is an
important factor in development of OME. Through a minimally invasive method (MEW) and
a very sensitive procedure (real time PCR), we were able to compare samples of healthy chil-
dren with those of children with OME. In the light of that result, the findings of some poten-
tially pathogenic bacteria in the middle ear of patients undergoing cochlear implant suggests
that their presence in the middle ear is independent of biofilm formation. Unfortunately, in
the present study no attempt was made to verify the presence of biofilm.
Otitis media with effusion and adenoid hypertrophy: Pathogens profile
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Concluding, in children with OME and adenoid hypertrophy we observed higher detection
rates of potentially pathogenic bacteria, but not respiratory viruses, by real-time PCR in middle
ear samples, as compared to control patients without adenoid hypertrophy. We did not
observe correlation between the microbiota of adenoid and middle ear, neither in OME chil-
dren nor in controls. This adds evidence that microbial community present in the middle ear
may be associated with persistence of fluid and pathogenesis of OME.
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